Literature DB >> 16354819

Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria.

Lilian R Pratt-Riccio1, Josué C Lima-Junior, Leonardo J M Carvalho, Michael Theisen, Erika C Espíndola-Mendes, Fátima Santos, Joseli Oliveira-Ferreira, Anna C Goldberg, Cláudio T Daniel-Ribeiro, Dalma M Banic.   

Abstract

The goal of this study was to evaluate the antibody response induced by Plasmodium falciparum glutamate-rich protein (GLURP) in naturally exposed individuals from the Brazilian Amazon region (Rondonia State). The results showed that most individuals had IgG against two well-defined regions within P. falciparum GLURP, the relatively conserved N-terminal nonrepeat region (R0) and the immunodominant repeat region (R2), 67% and 79%, respectively. The peptides S4 from R2 (53%) and P11 from R0 (49%) were identified as immunodominant B cell epitopes and induced higher levels of antibodies. The number of GLURP peptides recognized and the levels of IgG against S4 and P11 peptides showed a positive correlation with age and time of exposure in the malaria-endemic area studied. The antibody responses against GLURP epitopes appear to be modulated by HLA class II antigens. Interestingly, the GLURP immunodominant B cell epitopes in individuals from a Brazilian malaria-endemic area are distinguishable from those of the African malaria-endemic area. Considering the importance of GLURP as a malaria vaccine candidate and the increasing focus on the use of subunit vaccines in the control of infectious diseases, the concern of the influence of class II allele frequencies in ethnically diverse populations may be important before vaccine trials are conducted among people naturally exposed to malaria parasites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16354819

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  17 in total

1.  Malaria in Brazil: an overview.

Authors:  Joseli Oliveira-Ferreira; Marcus V G Lacerda; Patrícia Brasil; José L B Ladislau; Pedro L Tauil; Cláudio Tadeu Daniel-Ribeiro
Journal:  Malar J       Date:  2010-04-30       Impact factor: 2.979

2.  Promiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-gamma and IL-4 responses in individuals naturally exposed to malaria in the Brazilian Amazon.

Authors:  J C Lima-Junior; D M Banic; T M Tran; V S E Meyer; S G De-Simone; F Santos; L C S Porto; M T Q Marques; A Moreno; J W Barnwell; M R Galinski; J Oliveira-Ferreira
Journal:  Vaccine       Date:  2010-02-26       Impact factor: 3.641

3.  Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance.

Authors:  Fiona J McCallum; Kristina E M Persson; Freya J I Fowkes; Linda Reiling; Cleopatra K Mugyenyi; Jack S Richards; Julie A Simpson; Thomas N Williams; Paul R Gilson; Anthony N Hodder; Paul R Sanders; Robin F Anders; David L Narum; Chetan Chitnis; Brendan S Crabb; Kevin Marsh; James G Beeson
Journal:  J Leukoc Biol       Date:  2016-11-11       Impact factor: 4.962

4.  B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon.

Authors:  J C Lima-Junior; J Jiang; R N Rodrigues-da-Silva; D M Banic; T M Tran; R Y Ribeiro; V S E Meyer; S G De-Simone; F Santos; A Moreno; J W Barnwell; M R Galinski; J Oliveira-Ferreira
Journal:  Vaccine       Date:  2011-01-06       Impact factor: 3.641

5.  Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals.

Authors:  J C Lima-Junior; T M Tran; E V S Meyer; B Singh; S G De-Simone; F Santos; C T Daniel-Ribeiro; A Moreno; J W Barnwell; M R Galinski; J Oliveira-Ferreira
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

6.  Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area.

Authors:  Lilian Rose Pratt-Riccio; Daiana De Souza Perce-Da-Silva; Josué Da Costa Lima-Junior; Evelyn Kety Pratt Riccio; Marcelo Ribeiro-Alves; Fátima Santos; Mercia Arruda; Daniel Camus; Pierre Druilhe; Joseli Oliveira-Ferreira; Cláudio Tadeu Daniel-Ribeiro; Dalma Maria Banic
Journal:  Am J Trop Med Hyg       Date:  2017-10-10       Impact factor: 2.345

7.  Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian endemic area.

Authors:  Josué C Lima-Junior; Rodrigo N Rodrigues-da-Silva; Dalma M Banic; Jianlin Jiang; Balwan Singh; Gustavo M Fabrício-Silva; Luís C S Porto; Esmeralda V S Meyer; Alberto Moreno; Maurício M Rodrigues; John W Barnwell; Mary R Galinski; Joseli de Oliveira-Ferreira
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

8.  Genetic polymorphisms in the glutamate-rich protein of Plasmodium falciparum field isolates from a malaria-endemic area of Brazil.

Authors:  Lilian Rose Pratt-Riccio; Daiana de Souza Perce-da-Silva; Josué da Costa Lima-Junior; Michael Theisen; Fátima Santos; Cláudio Tadeu Daniel-Ribeiro; Joseli de Oliveira-Ferreira; Dalma Maria Banic
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-06       Impact factor: 2.743

9.  Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia.

Authors:  Hassen Mamo; Meral Esen; Anthony Ajua; Michael Theisen; Benjamin Mordmüller; Beyene Petros
Journal:  Malar J       Date:  2013-02-05       Impact factor: 2.979

10.  Cellular and humoral immune responses against the Plasmodium vivax MSP-1₁₉ malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of Brazil.

Authors:  Evelyn K P Riccio; Paulo R R Totino; Lilian R Pratt-Riccio; Vitor Ennes-Vidal; Irene S Soares; Maurício Martins Rodrigues; José Maria de Souza; Cláudio Tadeu Daniel-Ribeiro; Maria de Fátima Ferreira-da-Cruz
Journal:  Malar J       Date:  2013-09-16       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.